| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27863309P | 2009-10-09 | 2009-10-09 | |
| PCT/US2010/002722WO2011043827A1 (en) | 2009-10-09 | 2010-10-08 | Methods for preventing or treating sarcopenia and muscle atrophy in animals |
| Publication Number | Publication Date |
|---|---|
| IN2012DN02624Atrue IN2012DN02624A (en) | 2015-05-22 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2624DEN2012IN2012DN02624A (en) | 2009-10-09 | 2010-10-08 |
| Country | Link |
|---|---|
| US (1) | US9301941B2 (en) |
| EP (1) | EP2485740B1 (en) |
| JP (1) | JP6122638B2 (en) |
| CN (1) | CN102573857A (en) |
| AU (1) | AU2010303872B2 (en) |
| BR (1) | BR112012008238A2 (en) |
| CA (1) | CA2776950C (en) |
| ES (1) | ES2688447T3 (en) |
| IN (1) | IN2012DN02624A (en) |
| MX (1) | MX2012004118A (en) |
| RU (1) | RU2558534C2 (en) |
| WO (1) | WO2011043827A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11090313B2 (en) | 2010-05-20 | 2021-08-17 | University Of Iowa Research Foundation | Methods for inhibiting muscle atrophy |
| AU2012268036B2 (en) | 2011-06-06 | 2017-04-06 | THE UNITED STATES OF AMERICA as represented by THE SECRETARY OF STATE OF THE DEPARTMENT OF VETERANS AFFAIRS | Methods of inhibiting muscle atrophy |
| CN105708833A (en)* | 2011-10-18 | 2016-06-29 | 株式会社爱茉莉太平洋 | Sirt 1 activator including syringaresinol |
| KR102459500B1 (en)* | 2014-04-28 | 2022-10-26 | 산토리 홀딩스 가부시키가이샤 | Muscle atrophy inhibitor containing quercetin glycoside |
| HK1246601A1 (en) | 2015-02-13 | 2018-09-14 | 马斯公司 | Pet food feeding system |
| KR20170002846A (en) | 2015-06-30 | 2017-01-09 | (주)아모레퍼시픽 | Composition containing extract of soybean leaves for suppressing and preventing myopathy |
| GB201522304D0 (en)* | 2015-12-17 | 2016-02-03 | Mars Inc | Food product for reducing muscle breakdown |
| GB201721627D0 (en) | 2017-12-21 | 2018-02-07 | Mars Inc | Pet food product |
| CN108635571B (en)* | 2018-07-19 | 2021-10-22 | 西安交通大学医学院第一附属医院 | Application of irisin in the preparation of drugs for the prevention and treatment of severe acute pancreatitis |
| PH12022550801A1 (en)* | 2019-10-04 | 2023-09-25 | Suntory Holdings Ltd | Composition for suppression of decrease in muscle mass, prevention of decrease therein, maintenance thereof, recovery thereof or increase therein |
| KR102623198B1 (en)* | 2020-02-26 | 2024-01-10 | 한국 한의학 연구원 | Compositions for preventing, ameliorating or treating for muscle strengthening, muscle development, muscle differentiation, muscle regeneration or sarcopenia comprising Glycine soja extract as effective component |
| RU2756154C1 (en)* | 2020-11-13 | 2021-09-28 | Митхат Зульфугар-Оглы Гасанов | Method for diagnosing sarcopenia in patients with stage 5 chronic kidney disease receiving treatment with long-term hemodialysis |
| KR102803173B1 (en)* | 2021-02-22 | 2025-05-07 | 한국 한의학 연구원 | Composition for muscle strengthening, muscle development, muscle differentiation, muscle regeneration, for preventing, ameliorating or treating sarcopenia or muscle fatigue comprising compound isolated from Astragalus membranaceus extract as effective component |
| WO2023140407A1 (en)* | 2022-01-21 | 2023-07-27 | 경상국립대학교병원 | Pharmaceutical composition comprising coumestrol for preventing or treating sarcopenia |
| KR102803976B1 (en)* | 2022-04-06 | 2025-05-07 | 국립강릉원주대학교산학협력단 | Composition for strengthening muscle strength comprising extract of Styrax japonicas leaf extract |
| WO2025121473A1 (en)* | 2023-12-06 | 2025-06-12 | 경상국립대학교병원 | Pharmaceutical composition for preventing or alleviating sarcopenia, comprising acetylgenistin |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU166380B (en) | 1973-07-09 | 1975-03-28 | ||
| US6887499B2 (en) | 2000-05-22 | 2005-05-03 | Enitan A. Bababunmi | Formulation and method for treating skeletal muscle degeneration caused by malnutrition and disease |
| IL145540A0 (en)* | 2000-09-28 | 2002-06-30 | Pfizer Prod Inc | Use of growth hormone secretagogues in conjunction with physical exercise |
| AUPR846401A0 (en)* | 2001-10-25 | 2001-11-15 | Novogen Research Pty Ltd | 6-Hydroxy isoflavones, derivatives and medicaments involving same |
| JP5384777B2 (en)* | 2001-12-18 | 2014-01-08 | 有限会社大長企画 | Strong muscle agent, anti-inflammatory agent |
| WO2005007676A2 (en)* | 2003-07-10 | 2005-01-27 | Rajadhyaksha V J | Glycopeptides for the treatment of als and other metabolic and autoimmune disorders |
| WO2005072408A2 (en)* | 2004-01-29 | 2005-08-11 | Elixir Pharmaceuticals, Inc | Treating a viral disorder |
| WO2005089567A1 (en)* | 2004-03-17 | 2005-09-29 | Nestec S.A. | Compositions and methods for reducing or preventing obesity |
| JP2009537582A (en)* | 2006-05-24 | 2009-10-29 | ディーエスエム アイピー アセッツ ビー．ブイ． | New uses for organic compounds |
| KR101264820B1 (en) | 2006-08-24 | 2013-05-22 | 유니버시티 오브 테네시 리서치 파운데이션 | Substituted acylanilides and methods of use thereof |
| Publication number | Publication date |
|---|---|
| EP2485740A1 (en) | 2012-08-15 |
| CA2776950A1 (en) | 2011-04-14 |
| EP2485740B1 (en) | 2018-08-29 |
| ES2688447T3 (en) | 2018-11-02 |
| RU2012118686A (en) | 2013-11-20 |
| CN102573857A (en) | 2012-07-11 |
| RU2558534C2 (en) | 2015-08-10 |
| MX2012004118A (en) | 2012-05-08 |
| AU2010303872A1 (en) | 2012-04-19 |
| BR112012008238A2 (en) | 2017-06-06 |
| US20120238515A1 (en) | 2012-09-20 |
| AU2010303872B2 (en) | 2016-06-23 |
| EP2485740A4 (en) | 2013-04-03 |
| US9301941B2 (en) | 2016-04-05 |
| CA2776950C (en) | 2023-11-21 |
| JP6122638B2 (en) | 2017-04-26 |
| WO2011043827A1 (en) | 2011-04-14 |
| JP2013507361A (en) | 2013-03-04 |
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN02624A (en) | ||
| UA108198C2 (en) | Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use | |
| IN2012DN00624A (en) | ||
| JO3267B1 (en) | DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS | |
| IN2012DN00572A (en) | ||
| MY161495A (en) | Virus like particle compositions and methods of use | |
| MX2010004219A (en) | Cd19 binding agents and uses thereof. | |
| WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
| MX343135B (en) | Fumagillol type compounds and methods of making and using same. | |
| MX2009009761A (en) | Compositions and kits for treating influenza. | |
| IN2012DN02177A (en) | ||
| IN2012DN02730A (en) | ||
| IN2012DN00754A (en) | ||
| MX2010003013A (en) | Inhibition of angiogenesis. | |
| MX2009010960A (en) | Heterocyclic compounds and their methods of use. | |
| MY153948A (en) | Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| MX2011014019A (en) | Diazahomoadamantane derivatives and methods of use thereof. | |
| TN2011000482A1 (en) | Organic compounds and their uses | |
| MX2009005725A (en) | Methods and compositions for treating and monitoring treatment of il-13-associated disorders. | |
| IN2012DN02471A (en) | ||
| MX2012004548A (en) | Novel compositions for preventing and/or treating degenerative disorders of the central nervous system. | |
| MX2013011996A (en) | Methods for regulating sirtuin gene expression. | |
| MY164998A (en) | Isoquinolinone derivatives as nk3 antagonists | |
| EA201200428A1 (en) | COMPOSITION AND METHOD FOR TREATING OBESITY |